Registered entities
Re-vana Therapeutics Ltd
Reg. No. NI638333United Kingdom
Innovation
4 patent families (4 granted) — focus: Human necessities; filing pace steady. Cited 40 times.
| Year | Filings |
|---|---|
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
Social engagement
Social engagement: 2.9K social following, 7 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Visionary Ventures, Exsight Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Accelerator & incubator | 1 | 8% |
| Other / undisclosed | 6 | 46% |
Recent activity
17 Jun 2026
Event
BIO International Convention 2026
11 Jun 2026
Event
Retina World Congress 2026
29 May 2026
Leadership hire
Board Observer